{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T20:06:57Z","timestamp":1784664417130,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003718","name":"Korea Institute of Oriental Medicine","doi-asserted-by":"publisher","award":["KSN2225011"],"award-info":[{"award-number":["KSN2225011"]}],"id":[{"id":"10.13039\/501100003718","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Integrative Medicine Research"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.imr.2026.101335","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T23:34:48Z","timestamp":1775604888000},"page":"101335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"PA","title":["Efficacy and safety of modified Gwakjeongtang (herbal medicine) for diarrhea-predominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5257-2340","authenticated-orcid":false,"given":"Yujin","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6611-0147","authenticated-orcid":false,"given":"Na-Yeon","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3600-0806","authenticated-orcid":false,"given":"Ae-Ran","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7349-4596","authenticated-orcid":false,"given":"Ojin","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-9360-1754","authenticated-orcid":false,"given":"Haein","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4705-4538","authenticated-orcid":false,"given":"Heung Joo","family":"Yuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1322-767X","authenticated-orcid":false,"given":"Ki-Sun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6674-7700","authenticated-orcid":false,"given":"Jieun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2164-357X","authenticated-orcid":false,"given":"Jinsung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7997-7663","authenticated-orcid":false,"given":"Hyungjun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.imr.2026.101335_bib0001","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1053\/j.gastro.2016.02.031","article-title":"Bowel disorders","volume":"150","author":"Lacy","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imr.2026.101335_bib0002","doi-asserted-by":"crossref","first-page":"366","DOI":"10.3904\/kjm.2017.92.4.366","article-title":"Understanding the Rome IV: irritable bowel syndrome and functional diarrhea","volume":"92","author":"Kim","year":"2017","journal-title":"Korean J Med"},{"key":"10.1016\/j.imr.2026.101335_bib0003","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41575-020-0286-8","article-title":"Global burden of irritable bowel syndrome: trends, predictions and risk factors","volume":"17","author":"Black","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.imr.2026.101335_bib0004","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1001\/archinte.163.8.929","article-title":"The economic consequences of irritable bowel syndrome: a US employer perspective","volume":"163","author":"Leong","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.imr.2026.101335_bib0005","doi-asserted-by":"crossref","first-page":"E102","DOI":"10.1097\/SGA.0000000000000530","article-title":"Health-related quality of life in irritable bowel syndrome: a systematic review and meta-analysis","volume":"43","author":"Cassar","year":"2020","journal-title":"Gastroenterol Nurs"},{"key":"10.1016\/j.imr.2026.101335_bib0006","doi-asserted-by":"crossref","DOI":"10.3346\/jkms.2023.38.e126","article-title":"Survey-based analysis of the clinical treatment status of irritable bowel syndrome in Korea","volume":"38","author":"Koo","year":"2023","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.imr.2026.101335_bib0007","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.894122","article-title":"An overview of systematic reviews of herbal medicine for irritable bowel syndrome","volume":"13","author":"Jun","year":"2022","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.imr.2026.101335_bib0008","doi-asserted-by":"crossref","first-page":"532","DOI":"10.22246\/jikm.2021.42.4.532","article-title":"A survey on the clinical practice patterns of irritable bowel syndrome in Korean medicine","volume":"42","author":"Jun","year":"2021","journal-title":"J Korean Orient Intern Med"},{"key":"10.1016\/j.imr.2026.101335_bib0009","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000026635","article-title":"Gwakhyangjeonggi-san for irritable bowel syndrome: a protocol for systematic review and meta-analysis","volume":"100","author":"Park","year":"2021","journal-title":"Medicine"},{"key":"10.1016\/j.imr.2026.101335_bib0011","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/824605","article-title":"Effect of Korean herbal medicine combined with a probiotic mixture on diarrhea-dominant irritable bowel syndrome: a double-blind, randomized, placebo-controlled trial","author":"Ko","year":"2013","journal-title":"Evid Based Complem Altern Med"},{"key":"10.1016\/j.imr.2026.101335_bib0012","first-page":"376","article-title":"Observation on treatment of 58 cases of diarrhea-type irritable bowel syndrome with Huoxiang Zhengqi powder plus prescription","volume":"15","author":"Cao","year":"2003","journal-title":"Clin J Anhui Tradit Chin Med"},{"key":"10.1016\/j.imr.2026.101335_bib0013","first-page":"31","article-title":"Clinical study of jiawei huoxiang zhengqi powder combined with western medicine for treatment of diarrhea-predominant irritable bowel syndrome","volume":"43","author":"Qiu","year":"2011","journal-title":"J New Chin Med"},{"key":"10.1016\/j.imr.2026.101335_bib0014","first-page":"34","article-title":"Clinical study on modified Huoxiang Zhengqi Powder combined with western medicine for irritable bowel syndrome with diarrhea","volume":"54","author":"Jin","year":"2022","journal-title":"New Chin Med"},{"key":"10.1016\/j.imr.2026.101335_bib0015","first-page":"201","article-title":"Clinical study of diarrhea in irritable colon syndrome","volume":"7","author":"Han","year":"1986","journal-title":"J Korean Med"},{"key":"10.1016\/j.imr.2026.101335_bib0016","doi-asserted-by":"crossref","DOI":"10.1016\/j.imr.2020.100688","article-title":"Regulation and status of herbal medicine clinical trials in Korea","volume":"10","author":"Lee","year":"2021","journal-title":"Integr Med Res"},{"key":"10.1016\/j.imr.2026.101335_bib0017","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.2147\/IJGM.S447701","article-title":"Modified Gwakjeongtang for diarrhea-predominant irritable bowel syndrome: study protocol for a randomized, double-blind, placebo-controlled, pilot clinical trial","volume":"17","author":"Choi","year":"2024","journal-title":"Int J Gen Med"},{"key":"10.1016\/j.imr.2026.101335_bib0018","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1001\/jama.2025.4347","article-title":"CONSORT 2025 statement: updated guideline for reporting randomized trials","volume":"333","author":"Hopewell","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/j.imr.2026.101335_bib0019","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.imr.2026.101335_bib0020","doi-asserted-by":"crossref","first-page":"112","DOI":"10.7326\/M16-2977","article-title":"CONSORT extension for Chinese herbal medicine formulas 2017: recommendations, explanation, and elaboration","volume":"167","author":"Cheng","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.imr.2026.101335_bib0021","unstructured":"Committee for Medicinal Products for Human use (CHMP). Guideline on the evaluation of medicinal products for the treatment of irritable bowel syndrome. 2015."},{"key":"10.1016\/j.imr.2026.101335_bib0022","unstructured":"Center for Drug Evaluation and Research (CDER). Irritable Bowel Syndrome - clinical evaluation of products for treatment. 2012. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/irritable-bowel-syndrome-clinical-evaluation-products-treatment. Accessed May 31, 2023."},{"key":"10.1016\/j.imr.2026.101335_bib0023","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1046\/j.1365-2036.1997.142318000.x","article-title":"The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress","volume":"11","author":"Francis","year":"1997","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.imr.2026.101335_bib0024","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1023\/A:1018831127942","article-title":"Quality of life in persons with irritable bowel syndrome: development and validation of a new measure","volume":"43","author":"Patrick","year":"1998","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.imr.2026.101335_bib0025","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1007\/s11136-015-1205-2","article-title":"The EQ-5D-5L valuation study in Korea","volume":"25","author":"Kim","year":"2016","journal-title":"Qual Life Res"},{"key":"10.1016\/j.imr.2026.101335_bib0026","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1023\/A:1016351406336","article-title":"Development of the Korean versions of WHO Quality of Life scale and WHOQOL-BREF","volume":"11","author":"Min","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.imr.2026.101335_bib0027","doi-asserted-by":"crossref","first-page":"i5239","DOI":"10.1136\/bmj.i5239","article-title":"CONSORT 2010 statement: extension to randomised pilot and feasibility trials","volume":"355","author":"Eldridge","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.imr.2026.101335_bib0028","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/1471-2288-13-104","article-title":"An audit of sample sizes for pilot and feasibility trials being undertaken in the United Kingdom registered in the United Kingdom Clinical Research Network database","volume":"13","author":"Billingham","year":"2013","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.imr.2026.101335_bib0029","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157567","article-title":"Huoxiang Zhengqi oral liquid for irritable bowel syndrome with diarrhea: a multicenter, double-blind, randomized controlled trial","volume":"149","author":"Guo","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.imr.2026.101335_bib0030","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S2468-1253(21)00023-6","article-title":"The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis","volume":"6","author":"Bosman","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.imr.2026.101335_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115272","article-title":"The potential of dandelion in the fight against gastrointestinal diseases: a review","volume":"293","author":"Li","year":"2022","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.imr.2026.101335_bib0032","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3892\/ijmm.2015.2128","article-title":"The inhibitory effects of Geranium thunbergii on interferon-\u03b3- and LPS-induced inflammatory responses are mediated by Nrf2 activation","volume":"35","author":"Choi","year":"2015","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.imr.2026.101335_bib0033","first-page":"95","article-title":"An initial report on the antihyperglycemic and antinociceptive potential of Lablab purpureus beans","volume":"4","author":"Ahmed","year":"2015","journal-title":"World J Pharm Pharm Sci"},{"key":"10.1016\/j.imr.2026.101335_bib0034","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.arcmed.2020.12.011","article-title":"Antinociceptive synergy between metamizole and hesperidin in a model of visceral pain in mice","volume":"52","author":"Ventura-Martinez","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1016\/j.imr.2026.101335_bib0035","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3390\/antiox13101265","article-title":"Rosmarinic acid attenuates Salmonella enteritidis-induced inflammation via regulating TLR9\/NF-\u03bab signaling pathway and intestinal microbiota","volume":"13","author":"Yi","year":"2024","journal-title":"Antioxidants"}],"container-title":["Integrative Medicine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422026000521?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213422026000521?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T19:37:23Z","timestamp":1784662643000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213422026000521"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2213422026000521"],"URL":"https:\/\/doi.org\/10.1016\/j.imr.2026.101335","relation":{},"ISSN":["2213-4220"],"issn-type":[{"value":"2213-4220","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of modified Gwakjeongtang (herbal medicine) for diarrhea-predominant irritable bowel syndrome: A randomized, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"Integrative Medicine Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imr.2026.101335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Korea Institute of Oriental Medicine. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101335"}}